Brand name authorized in: Poland
The drug ACUVER contains one active pharmaceutical ingredient (API):
Betahistine dihydrochloride is a histamine-like drug in which pharmacological activity can be attributed to a specific effects and/or more direct influences on recovery mechanisms the vestibular nuclei. It has weak agonist activity at histamine H1 receptors and moderate antagonist activity at H3 receptors. Betahistine may increase blood flow to the cochlear region as well as to the whole brain.
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows: